obesity

https://www.mdpi.com/2072-6643/16/14/2305 This randomized controlled study examined the 4-week change in scores for the Center for Epidemiological Studies Depression (CES-D) questionnaire and the Patient Health Questionnaire (PHQ-9) in healthy overweight adults ingesting 2.95 g acetic acid (4...

Today we are joined by Dr. Rahul Mehan, a renowned urologist, who sheds light on the impact of Ozempic on sexual function, particularly in relation to erectile dysfunction. He is also the founder of Snip City, which specializes in vasectomy procedures. Ozempic, a semaglutide-based GLP-1...

Tirzepatide and semaglutide are both injectable medications used for weight loss and type 2 diabetes management, but they differ in their mechanisms of action and effectiveness. Here's a comparison of the two drugs: Mechanism of Action Tirzepatide: Dual glucose-dependent insulinotropic...

https://www.vumedi.com/video/aua-2024-insights-glp-1-receptor-agonists-and-mens-health/

* Diabetes can severely impact a man's ability to achieve and maintain an erection, as it damages the blood vessels, nerves, hormones, and erectile tissues required for healthy sexual function * Poorly controlled diabetes causes excess sugar to circulate in the blood, damaging arteries and...

ABSTRACT Introduction Functional hypogonadism is frequently found in obese men, particularly those with metabolic complications. Several possible therapeutic approaches could be considered. Areas covered An extensive search on Medline, Embase, and Cochrane databases was performed to...

Sign in for free to view! https://ir.verupharma.com/news-events/ir-calendar/detail/20240214-oppenheimer-34th-annual-healthcare-life-sciences-conference https://wsw.com/webcast/oppenheimer33/register.aspx?conf=oppenheimer33&page=veru&url=https://wsw.com/webcast/oppenheimer33/veru/2819844

https://ir.verupharma.com/news-events/press-releases/detail/196/veru-announces-fda-clearance-of-ind-application-to-initiate Veru Announces FDA Clearance of IND Application to Initiate Phase 2b Clinical Trial with Enobosarm to Treat Muscle Loss Associated with Weight Loss Drugs FDA IND...

Not sure what thread to put this under— I have gained about 51 pounds since 2018 of mostly abdominal fat. I have noticed at a higher weight, I am not feeling as though my TRT is working long enough. I’m guessing it is getting converted into E2 and/or not hitting the receptor sites as my Free T...

Fast Money host Melissa Lee talks with CNBC’s DJ Sixsmith about “Big Shot: The Ozempic Revolution,” which premieres on Thursday, February 29 at 10 pm ET. In this one-hour documentary, CNBC takes a deep dive into the global anti-obesity drug market, exploring the risks people are taking to get...

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011940/?fbclid=IwAR2tVliRNZld3ui2Kp70UeUrWFWsRaG5vphx8EF13fdB4aUn-vBc0v1aEKY_aem_AbqXSwyVpOvYCcYGlesCJW4UniV_Gzu02SPO3aX-qfs_8EF0ogIva-jCpe-_fAOuAmA#:~:text=In%20conclusion%2C%2024%2Dweek%20treatment,induced%20improvement%20of%20glycemic%20control

https://www.eurekaselect.com/article/137007 Abstract Obesity dramatically increases the risk of type 2 diabetes, fatty liver, hypertension, cardiovascular disease, and cancer, causing both declines in quality of life and life expectancy, which is a serious worldwide epidemic. At present, more...

Aaron Rand, Bill Brownstein, and Leslie Chesterman discuss weight loss and Ozempic ahead of the upcoming eating binge commonly known as Christmas with Dr. Joe Schwarcz, Director of McGill University's Office for Science and Society which has the mission of separating sense from nonsense.

I have had good testosterone results from using HCG alone (and not using testosterone). However, things are still not perfect, and I am not sure about the best next steps. First, let me tell you my story, which might be helpful for others: A year and a half ago, I had COVID and lost my...

https://vimeo.com/894561902?share=copy 56:10-1:12:31

https://vimeo.com/894561902?share=copy 44:10-56:10 s

https://vimeo.com/894561902?share=copy 32:40-44:06

https://vimeo.com/894561902?share=copy 18:32-32:26

https://vimeo.com/894561902?share=copy 1:50-18:23

Dr. Carolyn T. Bramante, MD, MPH presented a grand round on Anti-Obesity Pharmacotherapy for Long-Term Obesity Management. She discussed the complexity of obesity as a disease, the physiological and genetic factors affecting it, the importance of individualizing treatment, and the effectiveness...

Obstructive sleep apnoea syndrome (OSAS) is an under-recognized medical disease. The main risk factors for OSAS are male sex, older age, obesity, and metabolic syndrome, which are also associated with male hypogonadism (MH). Therefore, obesity has been classically identified as the most evident...

In this video, Mark Scholz and Mark Moyad discuss the pros and cons of weight loss drugs, particularly those that have shown significant weight loss results in patients. They emphasize that these drugs are not for cosmetic purposes, but for individuals with severe weight-related health issues...

https://www.hcplive.com/view/tirzepatide-bests-semaglutide-for-a1c-weight-loss-in-indirect-comparison-of-clinical-trial-data A network meta-analysis suggests tirzepatide may be more effective than semaglutide in reducing HbA1c and body weight in type 2 diabetes but may increase gastrointestinal...

https://www.hcplive.com/view/diabetes-dialogue-making-sense-of-semaglutide-in-type-1-diabetes In this episode, hosts sit down for a discussion around a recent NEJM report assessing the effects of semaglutide use in people with type 1 diabetes, including the implications of the findings and...

Abstract Obesity is currently one of the most serious public health problems which affect up to 30-40% of the population, and its prevalence is higher in men than in women. Complications of obesity include atherosclerosis, cardiovascular diseases, and type 2 diabetes mellitus, but it also has a...

This health chat features Dr. Anthony Leeds and Dr. Channa Jayasena discussing the link between obesity and male infertility. Key Takeaways: *They talk about the global scale of fertility problems and the significant drop in male infertility rates since the 1970s. *The rising prevalence of...

https://www.hcplive.com/view/semaglutide-could-eliminate-need-for-insulin-in-type-1-diabetes A case series of 10 patients with newly diagnosed type 1 diabetes provides insight into the beneficial effects of off-label semaglutide use on insulin use, HbA1c, and fasting C-peptide levels among...

Abstract Purpose of Review The history of multiple weight loss medications has been a concerning paradox based on an increased cardiovascular risk despite significant reductions in adipose tissue and weight. A new class of weight loss medications could change this past narrative based on...

Obesity is a chronic disease associated with increased morbidity and mortality. Bariatric surgery can lead to sustained long-term weight loss (WL) and improvement in multiple obesity-related complications, but it is not scalable at the population level. Over the past few years, gut hormone-based...

In this episode of Better Edge, Dr. Veronica Johnson and Dr. Eric Hungness from Northwestern Medicine discuss weight loss modalities. They highlight the effectiveness of weight loss surgery in addressing obesity and its associated medical problems. They also explore the evolution of non-surgical...

Introduction (00:00) Prof. John Stevenson (02:04) Q&A (22:20) Prof. Santiago Palacios (29:00) Q&A (53:57)